Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone

Transarterial chemoembolization is accepted therapy for hepatocellular carcinoma (HCC). No randomized trial has demonstrated superiority of chemoembolization compared with embolization, and the role of chemotherapy remains unclear. This randomized trial compares the outcome of embolization using mic...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of clinical oncology Ročník 34; číslo 17; s. 2046 - 2053
Hlavní autoři:	Brown, Karen T, Do, Richard K, Gonen, Mithat, Covey, Anne M, Getrajdman, George I, Sofocleous, Constantinos T, Jarnagin, William R, D'Angelica, Michael I, Allen, Peter J, Erinjeri, Joseph P, Brody, Lynn A, O'Neill, Gerald P, Johnson, Kristian N, Garcia, Alessandra R, Beattie, Christopher, Zhao, Binsheng, Solomon, Stephen B, Schwartz, Lawrence H, DeMatteo, Ronald, Abou-Alfa, Ghassan K
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 10.06.2016
Témata:	Aged Antibiotics, Antineoplastic - administration & dosage Antibiotics, Antineoplastic - adverse effects Carcinoma, Hepatocellular - blood supply Carcinoma, Hepatocellular - pathology Carcinoma, Hepatocellular - therapy Chemoembolization, Therapeutic - adverse effects Chemoembolization, Therapeutic - methods Doxorubicin - administration & dosage Doxorubicin - adverse effects Female Humans Liver Neoplasms - blood supply Liver Neoplasms - pathology Liver Neoplasms - therapy Male Microspheres Single-Blind Method
ISSN:	1527-7755
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!